The online version of this article (doi:10.1186/1475-2875-11-406) contains supplementary material, which is available to authorized users.
The authors declare they have no competing interests.
AA, DB and EL designed the study protocol and instructions. MM, KO, ID, OG, AG and SM carried out the monitoring and data collection process. AA and EL carried out the analysis. AA, SOC, BF, MS, JB, DB and EL drafted the manuscript. All authors have read and approved the manuscript.
As more point of care diagnostics become available, the need to transport and store perishable medical commodities to remote locations increases. As with other diagnostics, malaria rapid diagnostic tests (RDTs) must be highly reliable at point of use, but exposure to adverse environmental conditions during distribution has the potential to degrade tests and accuracy. In remote locations, poor quality diagnostics and drugs may have significant negative health impact that is not readily detectable by routine monitoring. This study assessed temperature and humidity throughout supply chains used to transport and store health commodities, such as RDTs.
Monitoring devices capable of recording temperature and humidity were deployed to Burkina Faso (8), Senegal (10), Ethiopia (13) and the Philippines (6) over a 13-month period. The devices travelled through government supply chains, usually alongside RDTs, to health facilities where RDTs are stored, distributed and used. The recording period spanned just over a year, in order to avoid any biases related to seasonal temperature variations.
In the four countries, storage and transport temperatures regularly exceeded 30.0°C; maximum humidity level recorded was above 94% for the four countries. In three of the four countries, temperatures recorded at central storage facilities exceeded pharmaceutical storage standards for over 20% of the time, in another case for a majority of the time; and sometimes exceeded storage temperatures at peripheral sites.
Malaria RDTs were regularly exposed to temperatures above recommended limits for many commercially-available RDTs and other medical commodities such as drugs, but rarely exceeded the recommended storage limits for particular products in use in these countries. The results underline the need to select RDTs, and other commodities, according to expected field conditions, actively manage the environmental conditions in supply chains in tropical and sub-tropical climates. This would benefit from a re-visit of current global standards on stability of medical commodities based in tropical and sub-tropical climatic zones.
WHO: Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 3 (2010-2011). 2011, Geneva: World Health Organization
WHO: Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 2 (2009). 2010, Geneva: World Health Organization
WHO: Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 1 (2008). 2009, Geneva: World Health Organization CrossRef
Chiodini PL, Bowers K, Jorgensen P, Barnwell JW, Grady KK, Luchavez J, Moody AH, Cenizal A, Bell D: The heat stability of Plasmodium lactate dehydrogenase-based and histidine-rich protein 2-based malaria rapid diagnostic tests. Trans R Soc Trop Med Hyg. 2007, 101: 331-337. 10.1016/j.trstmh.2006.09.007. CrossRefPubMed
WHO: Guidelines for the treatment of malaria. 2010, Geneva: World Health Organization, 2
WHO: World Malaria Report, 2011. 2011, World Health Organization, http://www.who.int/malaria/world_malaria_report_2011/9789241564403_eng.pdf,
Jorgensen P, Chanthap L, Rebueno A, Tsuyuoka R, Bell D: Malaria rapid diagnostic tests in tropical climates: the need for a cool chain. Am J Trop Med Hyg. 2006, 74: 750-754. PubMed
ICH: ICH harmonized tripartite guideline: Stability testing of new drug substances and products Q1A(R2): Current Step 4 version. 2003, Date accessed: 2012, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf
ICH: Q1F Stability Data Package for Registration Applications in Climatic Zones III and IV: Q1F Explanatory Note. 2006, Date accessed: August 2012, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1F/Q1F_Explanatory_Note.pdf
ASEAN: ASEAN Guideline on Stability Study of Drug Product; 9th ACCSQ-PPWG Meeting, Philippines, 21–24 Feb 2005. ASEAN Guideline on Stability Study of Drug Product; 9th ACCSQ-PPWG Meeting, Philippines. 2005, Date accessed: December 2012, http://www.hsa.gov.sg/publish/etc/medialib/hsa_library/health_products_regulation/western_medicines/files_guidelines.Par.61592.File.dat/ACTR_GuidelineforDrugProductStabilityStudy_Apr05.pdf
WHO: Annex 2 to WHO Technical Report Series, No. 953: Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. 2010
NMSA: Climatic and agro climatic resources of Ethiopia. NMSA Meteorological Research Report Series, vol. 1, No. 1. 1996, Addis Ababa: Ethiopia
Philippine Atmospheric, Geophysical and Astronomical Services Administration (PAGASA): National meteorology, climate data section. Book Philippine Atmospheric, Geophysical and Astronomical Services Administration (PAGASA). National Meteorology, Climate Data Section. 2004
WHO: Good practices for selecting and procuring rapid diagnostic tests for malaria. pp. 1–110. 2011, Geneva: WHO, 1-110.
WHO/FIND/CDC: Methods manual for product testing of malaria rapid diagnostic tests (version 1). 2008, Manila: World Health Organization - Regional Office for the Western Pacific
Results for malaria RDT lot testing. http://www.finddiagnostics.org/programs/malaria-afs/malaria/rdt_quality_control/lot_testing/malaria_rdt_lot_testing_results/,
Essential drugs practical guidelines. http://www.refbooks.msf.org/MSF_Docs/En/Essential_drugs/ED_en.pdf,
WHO/WPRO: Transport and Storage of Malaria RDTs. 2012, Date accessed: August 2012, http://www2.wpro.who.int/sites/rdt/using_rdts/rdt_transport_storage.htm
Lot testing of malaria rapid diagnostic tests (RDTs). http://www.finddiagnostics.org/programs/malaria-afs/malaria/rdt_quality_control/lot_testing/,
World Health Organization-Western Pacific Regional Office (WHO-WPRO) UDP, Foundation for Innovative New Diagnostics (FIND), Roll Back Malaria Partnership, President’s Malaria Initiative (PMI), UNICEF: Transporting, Storing, and Handling Malaria Rapid Diagnostic Tests at Central and Peripheral Storage Facilities. 2009, Arlington, Va: USAID | DELIVER PROJECT, Task Order 3; and Manila: WHO-WPRO
Mikhail AF, Leslie TJ, Mayan MI, Zekria R, Mohammad N, Hasanzai MA, Safi N, Whitty CJ, Rowland M: Field trial of three different Plasmodium vivax-detecting rapid diagnostic tests with and without evaporative cool box storage in Afghanistan. Malar J. 2011, 10: 169-10.1186/1475-2875-10-169. PubMedCentralCrossRefPubMed
World Health Organization-Western Pacific Regional Office (WHO-WPRO) UDP, Foundation for Innovative New Diagnostics (FIND), Roll Back Malaria Partnership, President’s Malaria Initiative (PMI), UNICEF: Transporting, Storing, and Handling Malaria Rapid Diagnostic Tests in Health Clinics. 2009, Arlington, Va: USAID | DELIVER PROJECT, Task Order 3; and Manila: WHO-WPRO
- Malaria rapid diagnostic test transport and storage conditions in Burkina Faso, Senegal, Ethiopia and the Philippines
Sheick Oumar Coulibaly
Mary Lorraine Mationg
Abeba G Tsadik
Sendeaw Maksha Feleke
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II